Google Cloud today announced it is partnering with Toolstation, one of the UK's fastest-growing suppliers of tools and building materials, to transform its digital commerce experience with artificial ...

Today at the Google Cloud Summit London, Additive Catchments and Google Cloud announced a strategic collaboration to scale trusted, AI-powered infrastructure for river health in the UK. Their goal: to ...

The stock's fall snapped a three-day winning streak.

Vertex Pharmaceuticals Inc. closed 10.29% short of its 52-week high of $519.88, which the company achieved on November 8th.

The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock news and headlines to help you in your trading and investing decisions.

See the latest Vertex Pharmaceuticals Inc stock price (VRTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880.

A trial of Vertex's suzetrigine in neuropathic back pain met its primary objective, but shares in the company fell as investors reacted to the data.

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Read about Vertex Pharmaceuticals Inc (VRTX:XNAS) stock and today's latest news and financial updates.